Results 11 to 20 of about 14,552,787 (242)
No effects of mitomycin-C in primary trabeculectomies in Sweden
SAGE Open Medicine, 2018 Aim: To evaluate the results of a long-term follow-up after two different types of surgical techniques: trabeculectomy with or without mitomycin-C. Materials and methods: This study is a retrospective chart review of patients operated on with a primary ...
Marcelo Ayala
doaj +2 more sources
Journal of the Scientific Society, 2012 Introduction to the use of Mitomycin C in ophthalmology was a significant development in the 1960s. Its use and application in ophthalmology has been increasing in recent years, because of its modulatory effects on wound healing.
Rekha Mudhol, N D Zingade, R S Mudhol
doaj +2 more sources
Surgical outcomes of Ahmed Glaucoma Valve Implantation surgery: With mitomycin C and without mitomycin C [PDF]
Journal of the Colleges of Medicine of South AfricaBackground: The Ahmed Glaucoma Valve (AGV) is a commonly used glaucoma drainage device (GDD) in the surgical management of glaucoma patients.
Hojatollah Jaldi, Tshilidzi van der Lecq
doaj +2 more sources
Mitomycin C in pterygium treatment [PDF]
International Journal of Ophthalmology, 2016 Pterygium is a benign lesion usually growing from the nasal side of the conjunctiva onto the cornea. Most cases of pterygium does not cause problem or requires specific treatment.
Thiago Gonçalves dos Santos Martins +4 more
doaj +3 more sources
Drug Design, Development and Therapy, 2018 Yi-Ping Fang,1,2 Pei-Yu Hu,1 Yaw-Bin Huang1,3 1School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, 2Department of Medical Research, Kaohsiung Medical University Hospital, 3Center for Stem Cell Research, Kaohsiung Medical University ...
Fang YP, Hu PY, Huang YB
doaj +1 more source
Clinical outcomes of PRESERFLO Microshunt procedure with mitomycin C alone versus with mitomycin C and bevacizumab [PDF]
Therapeutic Advances in OphthalmologyBackground: The PRESERFLO ® Microshunt procedure offers a safe and effective alternative to trabeculectomy procedure. The adjuvant use of anti-vascular endothelial growth factor (VEGF) with trabeculectomy has been well studied, yet little is known on the
Inas Gadelkarim +3 more
doaj +2 more sources
Topical application of mitomycin-C in corrosive esophageal strictures
Journal of Indian Association of Pediatric Surgeons, 2005 Introduction: Corrosive ingestion is the major cause of esophageal stricture in our country. Mitomycin-C, an anthracycline derived from Streptomyces caespitosus, has both antineoplastic and antiproliferative properties. Use of mitomycin-C have been well
Kumar Arun, Bhatnagar V
doaj +3 more sources
Endoscopic Ostium Assessment Following Endonasal Dacryocystorhinostomy with Mitomycin C Application [PDF]
Al Ameen Journal of Medical Sciences, 2012 Aim: The aim of the study is to visualize the patency and measure the ostium size at the end of Endonasal DCR with mitomycin C (MMC) versus control and to assess the role of Mitomycin C in maintaining patency of nasolacrimal drainage system.
R.R. Mudhol +3 more
doaj +1 more source
Transconjunctival penetration of mitomycin C
Indian Journal of Ophthalmology, 2008 Aims: The study was performed to estimate transconjunctival penetration of mitomycin C (MMC) to Tenon′s tissue following application over the intact conjunctiva before routine trabeculectomy. Settings and Design: Institution-based case series.
Velpandian T +3 more
doaj +4 more sources
Heliyon, 2023 The morphological response of HepG2 cells to mitomycin C was analyzed using a multichannel quartz crystal microbalance system equipped with a home-built movable microscope that enables the simultaneous acquisition of cell images and measurements of eight-
Hiroshi Muramatsu +3 more
doaj +1 more source